
Guillermo Garcia-Manero, MD, discusses how the recently approved combination regimen of decitabine and cedazuridine fits into the treatment landscape for patients with myelodysplastic syndromes.
Guillermo Garcia-Manero, MD, is a medical oncologist at The University of Texas MD Anderson Cancer Center in Houston.